2Andrawiss M. Cervical cancer vaccines available in 2005[J].Drug Discovery Today,2005,(14):9492950.
3JU Xingzhu,YANG Jinming,ZHOU Xiaoyan. EMMPRIN expression as a progno sticfactorin radio therapy of cervical cancer[J].Clinical Cancer Research,2008,(02):494249.
5Sarian LO, Derchain SF, Andrade LA, et al. HPV DNA test and Pap smear in detection of residual and recurrent disease following loop electrosurgical excision procedure of high-grade cervical intraepithelial neoplasia. Gynecol Oncol, 2004,94 : 181-186.
6Numnum TM, Kirby To, Leath CA 3rd, et al. A prospective evaluation of "see and treat" in women with HSIL . Pap smear results : is this an appropriate strategy? J Low Genit Tract Dis, 2005,9:2-6.
7Livasy CA, Maygarden SJ, Rajaratnam CT, et al. Predictors of recurrent dysplasia after a cervical loop electrocautery excision procedure for CIN-3: a study of margin, endocervical gland, and quadrant involvement . Mod Pathol, 1999,12 : 233-238.
8Reich O, Pickel H, Lahousen M, et al. Cervical intraepithelial neoplasia Ⅲ: long-term outcome after cold-knife conization with clear margins. Obstet Gynecol, 2001,97:428-430.
9Kang SB, Roh JW, Kim JW, et al. A comparison of the therapeutic efficacies of large loop excision of transformation zone and hysterectomy for the treatment of cervical intraepithelial neoplasia Ⅲ.Int J Gynecol Cancer, 2001,11:387-391.
10Corona Gutierrez CM, Tinoco A, Navarro T, et al. Therapeutic vaccination with MVAE2 can eliminate precancerous lesions associated with infection by oncogenic human papillomavims. Human Gene Ther, 2004, 15:421-431.
